Publicacións nas que colabora con Javier Navarro Zaragoza (16)

2021

  1. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis

    Pharmacology Biochemistry and Behavior, Vol. 201

2020

  1. Cardiac protective role of heat shock protein 27 in the stress induced by drugs of abuse

    International Journal of Molecular Sciences, Vol. 21, Núm. 10

  2. Conditioned aversive memory associated with morphine withdrawal increases brain-derived neurotrophic factor in dentate gyrus and basolateral amygdala

    Addiction Biology, Vol. 25, Núm. 4

2019

  1. Binge ethanol and MDMA combination exacerbates HSP27 and Trx-1 (biomarkers of toxic cardiac effects) expression in right ventricle

    Life Sciences, Vol. 220, pp. 50-57

  2. Pharmacological modulation of the behavioral effects of social defeat in memory and learning in male mice

    Psychopharmacology, Vol. 236, Núm. 9, pp. 2797-2810

2017

  1. Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal

    Addiction Biology, Vol. 22, Núm. 2, pp. 342-353

  2. Repeated social defeat and the rewarding effects of cocaine in adult and adolescent mice: dopamine transcription factors, proBDNF signaling pathways, and the TrkB receptor in the mesolimbic system

    Psychopharmacology, Vol. 234, Núm. 13, pp. 2063-2075

2015

  1. Binge ethanol and MDMA combination exacerbates toxic cardiac effects by inducing cellular stress

    PLoS ONE, Vol. 10, Núm. 10

  2. Erratum: Binge ethanol and MDMA combination exacerbates toxic cardiac effects by inducing cellular stress (PLoS ONE 10:10 (e0141502) (DOI:10.1371/journal.pone.0141502))

    PLoS ONE

2014

  1. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: Role of corticotropin-releasing factor (CRF) 1 receptor

    Toxicology and Applied Pharmacology, Vol. 275, Núm. 1, pp. 28-35

  2. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR)

    Toxicology, Vol. 326, pp. 36-43

2013

  1. Correction: Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc) (PLoS ONE)

    PLoS ONE

2012

  1. Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal

    British Journal of Pharmacology, Vol. 166, Núm. 7, pp. 2136-2147

  2. Role of Corticotropin-Releasing Factor (CRF) Receptor-1 on the Catecholaminergic Response to Morphine Withdrawal in the Nucleus Accumbens (NAc)

    PLoS ONE, Vol. 7, Núm. 10

2011

  1. CRF 2 mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats

    British Journal of Pharmacology, Vol. 162, Núm. 4, pp. 851-862

2010

  1. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal

    Molecular Pharmacology, Vol. 77, Núm. 5, pp. 864-873